ES2104339T3 - Nuevas particulas proteinicas. - Google Patents
Nuevas particulas proteinicas.Info
- Publication number
- ES2104339T3 ES2104339T3 ES94902961T ES94902961T ES2104339T3 ES 2104339 T3 ES2104339 T3 ES 2104339T3 ES 94902961 T ES94902961 T ES 94902961T ES 94902961 T ES94902961 T ES 94902961T ES 2104339 T3 ES2104339 T3 ES 2104339T3
- Authority
- ES
- Spain
- Prior art keywords
- sequence
- amino acids
- new protein
- protein particles
- epitope
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002245 particle Substances 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 150000001413 amino acids Chemical class 0.000 abstract 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 238000001338 self-assembly Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
- C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/735—Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929227068A GB9227068D0 (en) | 1992-12-29 | 1992-12-29 | Novel proteinaceous particles |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2104339T3 true ES2104339T3 (es) | 1997-10-01 |
Family
ID=10727292
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES94902961T Expired - Lifetime ES2104339T3 (es) | 1992-12-29 | 1993-12-24 | Nuevas particulas proteinicas. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US6060064A (de) |
| EP (1) | EP0677111B1 (de) |
| JP (1) | JPH08505768A (de) |
| AT (1) | ATE153071T1 (de) |
| AU (1) | AU5711294A (de) |
| DE (1) | DE69310768T2 (de) |
| ES (1) | ES2104339T3 (de) |
| GB (1) | GB9227068D0 (de) |
| WO (1) | WO1994014969A1 (de) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7128911B2 (en) | 2001-01-19 | 2006-10-31 | Cytos Biotechnology Ag | Antigen arrays for treatment of bone disease |
| US7094409B2 (en) | 2001-01-19 | 2006-08-22 | Cytos Biotechnology Ag | Antigen arrays for treatment of allergic eosinophilic diseases |
| US7247297B2 (en) * | 2001-09-14 | 2007-07-24 | The University Of Chicago | Use of DF3/MUC1 regulated expression in gene therapy |
| BR0213117A (pt) | 2001-10-05 | 2004-09-21 | Cytos Biotechnology Ag | Conjugados peptìdeo angiotensina-veìculo e seus usos |
| US7115266B2 (en) | 2001-10-05 | 2006-10-03 | Cytos Biotechnology Ag | Angiotensin peptide-carrier conjugates and uses thereof |
| US7285289B2 (en) * | 2002-04-12 | 2007-10-23 | Nagy Jon O | Nanoparticle vaccines |
| US20080233181A1 (en) * | 2002-04-12 | 2008-09-25 | Nagy Jon O | Nanoparticle adjuvants for sub-unit vaccines |
| NZ537688A (en) | 2002-07-19 | 2007-01-26 | Cytos Biotechnology Ag | Vaccine compositions containing amyloid beta1-6 antigen arrays for treating and/or attenuating Alzheimer's disease |
| US7537767B2 (en) | 2003-03-26 | 2009-05-26 | Cytis Biotechnology Ag | Melan-A- carrier conjugates |
| NZ542323A (en) | 2003-03-26 | 2008-07-31 | Cytos Biotechnology Ag | Melan-A peptide analogue-virus-like-particle conjugates |
| EP1989326A4 (de) | 2006-01-17 | 2009-09-30 | Health Research Inc | Heteroduplex-verfolgungstest |
| DK2069503T3 (da) * | 2006-11-15 | 2016-02-15 | Folia Biotech Inc | Papayamosaikvirus-baserede vacciner mod influenza |
| EP2262480B1 (de) | 2008-03-04 | 2018-02-14 | Liquidia Technologies, Inc. | Immunomodulator-teilchen |
| WO2010025425A1 (en) | 2008-08-29 | 2010-03-04 | Angros Lee H | Multiplexed microscope slide staining apparatus |
| WO2011119920A2 (en) | 2010-03-25 | 2011-09-29 | Oregon Health & Science University | Cmv glycoproteins and recombinant vectors |
| TWI526539B (zh) | 2010-12-22 | 2016-03-21 | 苜蓿股份有限公司 | 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp |
| DK2691530T3 (en) | 2011-06-10 | 2018-05-22 | Univ Oregon Health & Science | CMV GLYCOPROTEIN AND RECOMBINANT VECTORS |
| AU2012216792A1 (en) | 2011-09-12 | 2013-03-28 | International Aids Vaccine Initiative | Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies |
| US9402894B2 (en) | 2011-10-27 | 2016-08-02 | International Aids Vaccine Initiative | Viral particles derived from an enveloped virus |
| ES2631608T3 (es) | 2012-06-27 | 2017-09-01 | International Aids Vaccine Initiative | Variante de la glicoproteína Env del VIH-1 |
| EP2848937A1 (de) | 2013-09-05 | 2015-03-18 | International Aids Vaccine Initiative | Verfahren zur Identifizierung neuartiger HIV-1-Immunogene |
| EP2873423B1 (de) | 2013-10-07 | 2017-05-31 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
| EP3069730A3 (de) | 2015-03-20 | 2017-03-15 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
| EP3072901A1 (de) | 2015-03-23 | 2016-09-28 | International Aids Vaccine Initiative | Lösliche hiv-1-hüllglykoproteintrimere |
| JP7059179B2 (ja) | 2015-10-20 | 2022-04-25 | アンスティチュ ナショナル ドゥ ラ サンテ エ ドゥ ラ ルシェルシュ メディカル | 遺伝子操作のための方法及び製品 |
-
1992
- 1992-12-29 GB GB929227068A patent/GB9227068D0/en active Pending
-
1993
- 1993-12-24 DE DE69310768T patent/DE69310768T2/de not_active Expired - Fee Related
- 1993-12-24 JP JP6514974A patent/JPH08505768A/ja active Pending
- 1993-12-24 AU AU57112/94A patent/AU5711294A/en not_active Abandoned
- 1993-12-24 WO PCT/GB1993/002656 patent/WO1994014969A1/en active IP Right Grant
- 1993-12-24 AT AT94902961T patent/ATE153071T1/de not_active IP Right Cessation
- 1993-12-24 EP EP94902961A patent/EP0677111B1/de not_active Expired - Lifetime
- 1993-12-24 ES ES94902961T patent/ES2104339T3/es not_active Expired - Lifetime
- 1993-12-24 US US08/492,076 patent/US6060064A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH08505768A (ja) | 1996-06-25 |
| DE69310768T2 (de) | 1997-12-04 |
| AU5711294A (en) | 1994-07-19 |
| WO1994014969A1 (en) | 1994-07-07 |
| US6060064A (en) | 2000-05-09 |
| DE69310768D1 (de) | 1997-06-19 |
| EP0677111B1 (de) | 1997-05-14 |
| GB9227068D0 (en) | 1993-02-24 |
| EP0677111A1 (de) | 1995-10-18 |
| ATE153071T1 (de) | 1997-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2104339T3 (es) | Nuevas particulas proteinicas. | |
| DE69227041D1 (de) | Expression und reinigung von rekombinantem, löslichem gewebefaktor | |
| ES2124276T3 (es) | Anticuerpos perfeccionados contra plasmodium falciparum. | |
| ATE207535T1 (de) | Hepatitis-b-oberflächenantigen enthaltendes peptid | |
| HK1012841A1 (en) | Pharmaceutical composition for the treatment or prevention of amalignant tumor | |
| ATE159727T1 (de) | Kleinste erkennungseinheit eines pem-mucin- ''tandem repeat''-spezifischen monoklonalen antikoerpers | |
| EP0284587A3 (de) | Synthetische Peptid-Antigene für den Nachweis von HIV-1-Infektionen | |
| KR900700507A (ko) | Htlv-1 감염 검출용 합성 펩티드 항원 | |
| AU616156B2 (en) | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections | |
| ES2129487T3 (es) | Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion. | |
| ATE193208T1 (de) | Verwendung synthetischer peptide zur induktion der toleranz gegen t- und b-zell epitope von autoantigenen | |
| ES2193216T3 (es) | Dipeptidil peptidasa iv y su procedimiento de preparacion. | |
| DE69126577D1 (de) | Antigenes Peptid zum Nachweis von Anti-Hepatitis-C-Virus-Antikörpern und dessen Verwendung | |
| SE8500712L (sv) | Peptidforening samt antiserum framstellt med anvendning av denna forening | |
| AR246856A1 (es) | Un metodo para producir extractos de levadura, extracto de levadura producido mediante dicho metodo. | |
| GB9311454D0 (en) | Pharmaceutical compositions | |
| CA2178635A1 (en) | Immunofluorescence assay for the detection of antibodies using recombinant antigens in insoluble form | |
| ES2168282T3 (es) | D-hidantoinasa recombinante, procedimiento para su preparacion y utilizacion. | |
| ATE155345T1 (de) | Gegengift immunsera | |
| DE69835426D1 (de) | Aktivierung von peptiden | |
| ATE192163T1 (de) | Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus | |
| IT1254147B (it) | Metodo di rivelazione di marcatori tumorali. | |
| EP0351244A3 (de) | Antikörper und Methoden für ihre Verwendung in Immuntests | |
| AU2624288A (en) | Hiv peptides, artificial hiv antigens and immunoassay kits | |
| AU88319S (en) | Vehicle tire |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 677111 Country of ref document: ES |